Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab.
Berinstein NL, Bhella S, Pennell NM, Cheung MC, Imrie KR, Spaner DE, Milliken V, Zhang L, Hewitt K, Boudreau A, Reis MD, Chesney A, Good D, Ghorab Z, Hicks LK, Piliotis E, Buckstein R. Berinstein NL, et al. Among authors: bhella s. Ann Hematol. 2015 May;94(5):813-23. doi: 10.1007/s00277-014-2288-5. Epub 2015 Jan 8. Ann Hematol. 2015. PMID: 25567231 Clinical Trial.
A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score.
Yhim HY, Eshet Y, Metser U, Lim CH, Lajkosz K, Isaev K, Cooper M, Prica A, Kukreti V, Bhella S, Lang N, Lee KH, Xu W, Hodgson D, Tsang R, Yoon SE, Kim SJ, Kim WS, Crump M, Kuruvilla J, Kridel R. Yhim HY, et al. Among authors: bhella s. Blood Adv. 2020 Nov 24;4(22):5762-5771. doi: 10.1182/bloodadvances.2020002814. Blood Adv. 2020. PMID: 33216888 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33704220
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation.
Law AD, Bhella S, Pasic I, Lam W, Michelis FV, Gerbitz A, Viswabandya A, Kumar R, Lipton JH, Mattsson J, Kim DDH. Law AD, et al. Among authors: bhella s. Ann Hematol. 2021 May;100(5):1311-1319. doi: 10.1007/s00277-021-04480-5. Epub 2021 Mar 12. Ann Hematol. 2021. PMID: 33710366
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Monteith BE, Venner CP, Cheung MC, Pater J, Shepherd L, Richardson H, Reece D, Gul E, Lalancette M, Castonguay V, Kukreti V, Tiedemann R, Phua C, Bhella S, Dudebout J, Sherry M, Yen H, Chen BE, Hay AE. Monteith BE, et al. Among authors: bhella s. Eur J Haematol. 2021 Sep;107(3):333-342. doi: 10.1111/ejh.13671. Epub 2021 Jun 23. Eur J Haematol. 2021. PMID: 34053112 Clinical Trial.
Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume.
Yhim HY, Eshet Y, Metser U, Lajkosz K, Cooper M, Prica A, Kukreti V, Bhella S, Lang N, Xu W, Rodin D, Hodgson D, Tsang R, Crump M, Kuruvilla J, Kridel R. Yhim HY, et al. Among authors: bhella s. Am J Hematol. 2022 May;97(5):583-591. doi: 10.1002/ajh.26500. Epub 2022 Feb 23. Am J Hematol. 2022. PMID: 35170780 Free article.
Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.
Lackraj T, Ben Barouch S, Medeiros JJF, Pedersen S, Danesh A, Bakhtiari M, Hong M, Tong K, Joynt J, Arruda A, Minden MD, Kuruvilla J, Bhella S, Kukreti V, Crump M, Prica A, Chen C, Deng Y, Xu W, Pugh TJ, Keating A, Dick JE, Abelson S, Kridel R. Lackraj T, et al. Among authors: bhella s. Am J Hematol. 2022 Dec;97(12):1538-1547. doi: 10.1002/ajh.26726. Epub 2022 Sep 26. Am J Hematol. 2022. PMID: 36087071 Free article.
31 results